|
1
|
Koval OA, Sakaeva GR, Fomin AS, Nushtaeva
AA, Semenov DV, Kuligina EV, Gulyaeva LF, Gerasimov AV and Richter
VA: Sensitivity of endometrial cancer cells from primary human
tumor samples to new potential anticancer peptide lactaptin. J
Cancer Res Ther. 11:345–351. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Di Cristofano A and Ellenson LH:
Endometrial carcinoma. Annu Rev Pathol. 2:57–85. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kadar N, Homesley HD and Malfetano JH:
Prognostic factors in surgical stage III and IV carcinoma of the
endometrium. Obstet Gynecol. 84:983–986. 1994.PubMed/NCBI
|
|
4
|
Morrow CP, Bundy BN, Kurman RJ, Creasman
WT, Heller P, Homesley HD and Graham JE: Relationship between
surgical-pathological risk factors and outcome in clinical stage I
and II carcinoma of the endometrium: A gynecologic oncology group
study. Gynecol Oncol. 40:55–65. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Haspel J and Grumet M: The L1CAM
extracellular region: A multi-domain protein with modular and
cooperative binding modes. Front Biosci. 8:s1210–s1225. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Rathjen FG and Schachner M:
Immunocytological and biochemical characterization of a new
neuronal cell surface component (L1 antigen) which is involved in
cell adhesion. EMBO J. 3:1–10. 1984.PubMed/NCBI
|
|
7
|
Pancook JD, Reisfeld RA, Varki N, Vitiello
A, Fox RI and Montgomery AM: Expression and regulation of the
neural cell adhesion molecule L1 on human cells of myelomonocytic
and lymphoid origin. J Immunol. 158:4413–4421. 1997.PubMed/NCBI
|
|
8
|
Debiec H, Christensen EI and Ronco PM: The
cell adhesion molecule L1 is developmentally regulated in the renal
epithelium and is involved in kidney branching morphogenesis. J
Cell Biol. 143:2067–2079. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Thor G, Probstmeier R and Schachner M:
Characterization of the cell adhesion molecules L1, N-CAM and J1 in
the mouse intestine. EMBO J. 6:2581–2586. 1987.PubMed/NCBI
|
|
10
|
Ebeling O, Duczmal A, Aigner S, Geiger C,
Schöllhammer S, Kemshead JT, Möller P, Schwartz-Albiez R and
Altevogt P: L1 adhesion molecule on human lymphocytes and
monocytes: Expression and involvement in binding to alpha v beta 3
integrin. Eur J Immunol. 26:2508–2516. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Altevogt P, Doberstein K and Fogel M:
L1CAM in human cancer. Int J Cancer. 138:1565–1576. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Colombo F and Meldolesi J: L1-CAM and
N-CAM: From adhesion proteins to pharmacological targets. Trends
Pharmacol Sci. 36:769–781. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Notaro S, Reimer D, Duggan-Peer M, Fiegl
H, Wiedermair A, Rössler J, Altevogt P, Marth C and Zeimet AG:
Evaluating L1CAM expression in human endometrial cancer using
qRT-PCR. Oncotarget. 7:40221–40232. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ryffel B, Woerly G, Greiner B, Haendler B,
Mihatsch MJ and Foxwell BM: Distribution of the cyclosporine
binding protein cyclophilin in human tissues. Immunology.
72:399–404. 1991.PubMed/NCBI
|
|
15
|
Nigro P, Pompilio G and Capogrossi MC:
Cyclophilin A: A key player for human disease. Cell Death Dis.
4:e8882013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bonfils C, Bec N, Larroque C, Del Rio M,
Gongora C, Pugnière M and Martineau P: Cyclophilin A as negative
regulator of apoptosis by sequestering cytochrome c. Biochem
Biophys Res Commun. 393:325–330. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Bosco DA, Eisenmesser EZ, Pochapsky S,
Sundquist WI and Kern D: Catalysis of cis/trans isomerization in
native HIV-1 capsid by human cyclophilin A. Proc Natl Acad Sci USA.
99:pp. 5247–5252. 2002; View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Brazin KN, Mallis RJ, Fulton DB and
Andreotti AH: Regulation of the tyrosine kinase Itk by the
peptidyl-prolyl isomerase cyclophilin A. Proc Natl Acad Sci USA.
99:pp. 1899–1904. 2002; View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Howard BR, Vajdos FF, Li S, Sundquist WI
and Hill CP: Structural insights into the catalytic mechanism of
cyclophilin A. Nat Struct Biol. 10:475–481. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Göthel SF and Marahiel MA: Peptidyl-prolyl
cis-trans isomerases, a superfamily of ubiquitous folding
catalysts. Cell Mol Life Sci. 55:423–436. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Fischer G, Tradler T and Zarnt T: The mode
of action of peptidyl prolyl cis/trans isomerases in vivo: Binding
vs. FEBS Lett. 426:17–20. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wu L, Wang Q, Yao J, Jiang H, Xiao C and
Wu F: MicroRNA let-7g and let-7i inhibit hepatoma cell growth
concurrently via downregulation of the anti-apoptotic protein
B-cell lymphoma-extra large. Oncol Lett. 9:213–218. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Xiang Y, Lu DL, Li JP, Yu CX, Zheng DL,
Huang X, Wang ZY, Hu P, Liao XH and Zhang TC: Myocardin inhibits
estrogen receptor alpha-mediated proliferation of human breast
cancer MCF-7 cells via regulating MicroRNA expression. IUBMB Life.
68:477–487. 2016. View
Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ren ZG, Dong SX, Han P and Qi J: miR-203
promotes proliferation, migration and invasion by degrading SIK1 in
pancreatic cancer. Oncol Rep. 35:1365–1374. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Liao XH, Lu DL, Wang N, Liu LY, Wang Y, Li
YQ, Yan TB, Sun XG, Hu P and Zhang TC: Estrogen receptor α mediates
proliferation of breast cancer MCF-7 cells via a
p21/PCNA/E2F1-dependent pathway. FEBS J. 281:927–942. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Liao XH, Li YQ, Wang N, Zheng L, Xing WJ,
Zhao DW, Yan TB, Wang Y, Liu LY, Sun XG, et al: Re-expression and
epigenetic modification of maspin induced apoptosis in MCF-7 cells
mediated by myocardin. Cell Signal. 26:1335–1346. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Liao XH, Wang Y, Wang N, Yan TB, Xing WJ,
Zheng L, Zhao DW, Li YQ, Liu LY, Sun XG, et al: Human chorionic
gonadotropin decreases human breast cancer cell proliferation and
promotes differentiation. IUBMB Life. 66:352–360. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Liao XH, Xiang Y, Yu CX, Li JP, Li H, Nie
Q, Hu P, Zhou J and Zhang TC: STAT3 is required for
MiR-17-5p-mediated sensitization to chemotherapy-induced apoptosis
in breast cancer cells. Oncotarget. 8:15763–15774. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Liao XH, Li JY, Dong XM, Wang X, Xiang Y,
Li H, Yu CX, Li JP, Yuan BY, Zhou J and Zhang TC: ERα inhibited
myocardin-induced differentiation in uterine fibroids. Exp Cell
Res. 350:73–82. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Song Z, Liu Z, Sun J, Sun FL, Li CZ, Sun
JZ and Xu LY: The MRTF-A/B function as oncogenes in pancreatic
cancer. Oncol Rep. 35:127–138. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhang WL, Lv W, Sun SZ, Wu XZ and Zhang
JH: miR-206 inhibits metastasis-relevant traits by degrading MRTF-A
in anaplastic thyroid cancer. Int J Oncol. 47:133–142. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Xin J, Zhang XK, Xin DY, Li XF, Sun DK, Ma
YY and Tian LQ: FUS1 acts as a tumor-suppressor gene by
upregulating miR-197 in human glioblastoma. Oncol Rep. 34:868–876.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Eisen MB, Spellman PT, Brown PO and
Botstein D: Cluster analysis and display of genome-wide expression
patterns. Proc Natl Acad Sci U S A. 95:pp. 14863–148681998;
|
|
34
|
Kurrey NK, Jalgaonkar SP, Joglekar AV,
Ghanate AD, Chaskar PD, Doiphode RY and Bapat SA: Snail and slug
mediate radioresistance and chemoresistance by antagonizing
p53-mediated apoptosis and acquiring a stem-like phenotype in
ovarian cancer cells. Stem Cells. 27:2059–2068. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan
A, Zhou AY, Brooks M, Reinhard F, Zhang CC, Shipitsin M, et al: The
epithelial-mesenchymal transition generates cells with properties
of stem cells. Cell. 133:704–715. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Morel AP, Lièvre M, Thomas C, Hinkal G,
Ansieau S and Puisieux A: Generation of breast cancer stem cells
through epithelial-mesenchymal transition. PLoS One. 3:e28882008.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Santisteban M, Reiman JM, Asiedu MK,
Behrens MD, Nassar A, Kalli KR, Haluska P, Ingle JN, Hartmann LC,
Manjili MH, et al: Immune-induced epithelial to mesenchymal
transition in vivo generates breast cancer stem cells. Cancer Res.
69:2887–2895. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Myatt SS, Wang J, Monteiro LJ, Christian
M, Ho KK, Fusi L, Dina RE, Brosens JJ, Ghaem-Maghami S and Lam EW:
Definition of microRNAs that repress expression of the tumor
suppressor gene FOXO1 in endometrial cancer. Cancer Res.
70:367–377. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Huang YW, Liu JC, Deatherage DE, Luo J,
Mutch DG, Goodfellow PJ, Miller DS and Huang TH: Epigenetic
repression of microRNA-129-2 leads to overexpression of SOX4
oncogene in endometrial cancer. Cancer Res. 69:9038–9046. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Dong P, Kaneuchi M, Watari H, Hamada J,
Sudo S, Ju J and Sakuragi N: MicroRNA-194 inhibits epithelial to
mesenchymal transition of endometrial cancer cells by targeting
oncogene BMI-1. Mol Cancer. 10:992011. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Dellinger TH, Smith DD, Ouyang C, Warden
CD, Williams JC and Han ES: L1CAM is an independent predictor of
poor survival in endometrial cancer-An analysis of the cancer
genome atlas (TCGA). Gynecol Oncol. 141:336–340. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Friel AM, Sergent PA, Patnaude C, Szotek
PP, Oliva E, Scadden DT, Seiden MV, Foster R and Rueda BR:
Functional analyses of the cancer stem cell-like properties of
human endometrial tumor initiating cells. Cell Cycle. 7:242–249.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Tanaka Y, Terai Y, Kawaguchi H, Fujiwara
S, Yoo S, Tsunetoh S, Takai M, Kanemura M, Tanabe A and Ohmichi M:
Prognostic impact of EMT
(epithelial-mesenchymal-transition)-related protein expression in
endometrial cancer. Cancer Biol Ther. 14:13–19. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Huszar M, Pfeifer M, Schirmer U, Kiefel H,
Konecny GE, Ben-Arie A, Edler L, Münch M, Müller-Holzner E,
Jerabek-Klestil S, et al: Up-regulation of L1CAM is linked to loss
of hormone receptors and E-cadherin in aggressive subtypes of
endometrial carcinomas. J Pathol. 220:551–561. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Singh A and Settleman J: EMT, cancer stem
cells and drug resistance: An emerging axis of evil in the war on
cancer. Oncogene. 29:4741–4751. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Götte M, Wolf M, Staebler A, Buchweitz O,
Kelsch R, Schüring AN and Kiesel L: Increased expression of the
adult stem cell marker Musashi-1 in endometriosis and endometrial
carcinoma. J Pathol. 215:317–329. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Bao S, Wu Q, Li Z, Sathornsumetee S, Wang
H, McLendon RE, Hjelmeland AB and Rich JN: Targeting cancer stem
cells through L1CAM suppresses glioma growth. Cancer Res.
68:6043–6048. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Held-Feindt J, Schmelz S, Hattermann K,
Mentlein R, Mehdorn HM and Sebens S: The neural adhesion molecule
L1CAM confers chemoresistance in human glioblastomas. Neurochem
Int. 61:1183–1191. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Yoon H, Min JK, Lee DG, Kim DG, Koh SS and
Hong HJ: L1 cell adhesion molecule and epidermal growth factor
receptor activation confer cisplatin resistance in intrahepatic
cholangiocarcinoma cells. Cancer Lett. 316:70–76. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Li Z, Min W and Gou J: Knockdown of
cyclophilin A reverses paclitaxel resistance in human endometrial
cancer cells via suppression of MAPK kinase pathways. Cancer
Chemother Pharmacol. 72:1001–1011. 2013. View Article : Google Scholar : PubMed/NCBI
|
